Pharmacokinetic/ Pharmacodynamics in Drug Development and Evaluation
Who should take these points in consideration ?
1. Industry: surely ! (efficacy both in short and long term) but what do they do with that ?
2. Clinicians: more and more (optimizing therapy in long term) but they often feel alone or insufficiently informed
3. Regulatory bodies (to better appraise new drugs) but they wish to be certain that this is the correct way !